MedPath

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy

Not Applicable
Completed
Conditions
Sars-CoV2
Interventions
Diagnostic Test: biological samples day of delivery
Registration Number
NCT04402918
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The study evaluates the distribution of immunological and virological profiles of newborns patients. Mothers of these children have a proven infection to SARS Cov-2 during pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • pregnant woman
  • diagnosed with Sars Cov-2 during pregnancy
  • singleton or twin pregnancy
  • informed consent
Exclusion Criteria
  • virological or serological samples not done the day of delivery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
pregnancy patients diagnosed with SARS Cov2 during pregnancybiological samples day of deliveryDelivery day biological samples from the mother and the newborn will be performed
Primary Outcome Measures
NameTimeMethod
Vrological profile of newborns.day of delivery

Describe the virological profile of newborns whose mother have been diagnosed with Sars Cov2 during pregnancy : Covid+ or covid-

Immunological profile of newborns.day of delivery

Describe the immunological profile of newborns whose mother have been diagnosed with Sars Cov2 during pregnancy : IgG and/or IgM or absence

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Besancon

🇫🇷

Besancon, France

© Copyright 2025. All Rights Reserved by MedPath